Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Feb 25 | LYEL Lyell Immunopharma | Common Stock | Grant | Acquire A | No | No | 0 | 112,500 | 0.00 | 176,696 |
10 Feb 25 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 0.5535 | 56,250 | 31.13 k | 56,250 |
10 Feb 25 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 0.5535 | 450,000 | 249.08 k | 450,000 |
9 Feb 24 | LYEL Lyell Immunopharma | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 52,700 |
9 Feb 24 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.8 | 400,000 | 720.00 k | 400,000 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.04 | 800,000 | 4.83 mm | 0 |
16 Nov 23 | LYEL Lyell Immunopharma | Stock Option Common Stock | Grant | Acquire A | No | No | 1.87 | 800,000 | 1.50 mm | 800,000 |